Behaviour of regional adrenergic outflow in mild-to-moderate renal failure

Journal of Hypertension

Volumn 27, Issue 3, 2009, Pages 562-566

  Grassi, Guido ^a,b,c,e   Seravalle, Gino ^c   Arenare, Francesca ^a   Buccianti, Gherardo ^d   Furiani, Silvia ^d   Ilardo, Valeria ^a   Bolla, Gianbattista ^b   Mancia, Giuseppe ^a,b,c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b Fisiologia Clinica e Ipertensione   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d Ospedale Bassini   (Italy)

^e SAN GERARDO HOSPITAL   (Italy)

Author keywords

Chronic renal failure; Microneurography; Plasma norepinephrine; Reflex cardiovascular control; Sympathetic nervous system

Indexed keywords

ADRENERGIC STIMULATION; ADULT; AROUSAL; ARTERIAL PRESSURE; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART RATE; HUMAN; MALE; NERVE CONDUCTION; NEUROGRAPHY; NORADRENALIN BLOOD LEVEL; POSTGANGLIONIC NERVE; PRIORITY JOURNAL; SKELETAL MUSCLE; SKIN; SYMPATHETIC NERVE; SYMPATHETIC TONE;

EID: 67649550010     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32831fb371     Document Type: Article

References (35)

1. Hataway DK, Cashion AK, Milstead EJ, Winsett RP, Cowan PA, Wicks MN, Gaber AO. Autonomic dysregulation in patients awaiting kidney transplantation. Am J Kidney Dis 1998; 32:221-229.
2. Robinson TG, Carr SJ. Cardiovascular autonomic dysfunction in uremia. Kidney Int 2002; 62:1921-1932.
3. Axelrod S, Lishner M, Oz O, Bernheim J, Ravid M. Spectral analysis of fluctuations in heart rate: an objective evaluation of autonomic nervous control in chronic renal failure. Nephron 1987; 45:202-206.
4. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327:1912-1918.
5. Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ. Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. J Am Soc Nephrol 2001; 12:2427-2433.
6. HausbergM, Kosch M,Harmelink P,BarenbrockM, Hohage H,KistersK, et al. Sympathetic nerve activity in end-stage renal disease. Circulation 2002; 106:1974-1979.
7. Klein IH, Ligtenberg G, Neumann J, Oey PL, Koomans HA, Blankestijn PJ. Sympathetic nerve activity is inappropriately increased in chronic renal disease. J Am Soc Nephrol 2003; 14:3239-3244.
8. Zilch O, Vos PF, Oey PL, Cramer MJ, Ligtenberg G, Koomans HA, Blankestijn PJ. Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis. J Hypertens 2007; 25:1285-1289.
9. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002; 105:1354-1359.
10. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, et al. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999; 340:1321-1328.
11. Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ. Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J Am Soc Nephrol 2003; 14:425-430.
12. Neumann J, Ligtenberg G, Oey L, Koomans HA, Blankestijn PJ. Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure. J Am Soc Nephrol 2004; 15:2902-2907.
13. Hagbarth KE, Hallin RG, Hongell A, Torebjörk HE, Wallin BG. General characteristics of sympathetic activity in human skin nerves. Acta Physiol Scand 1972; 84:164-176.
14. Delius W, Hagbarth KE, Hongell A, Wallin BG. Manoeuvres affecting sympathetic outflow in human skin nerves. Acta Physiol Scand 1972; 84:177-186.
15. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al., National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139:137-147.
16. Grassi G, Colombo M, Seravalle G, Spaziani D, Mancia G. Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension 1998; 31:64-67.
17. Pozzi M, Grassi G, Redaelli E, Dell'oro R, Ratti L, Redaelli A, et al. Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis. Hepatology 2001; 34:1113-1118.
18. Vallbo AB, Hagbarth KE, Torebjörk HE, Wallin BG. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 1979; 59:919-957.
19. Sahn DJ, DeMaria RB, Kisslo J, Weiman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1076-1083.
20. Schiller NB, Shah PM, CrawfordM,DeMariaA,DevereuxR,Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
21. Devereux RB, Reicheck N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55:613-616.
22. Hjemdahl P, Daleskong M, Kanan T. Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci 1979; 25:131-138.
23. Pickering TG, Gribbin B, Oliver DO. Baroreflex sensitivity in patients on long-term haemodialysis. Clin Sci 1972; 43:645-657.
24. Grassi G, Parati G, Pomidossi G, Giannattasio C, Casadei R, Bolla GB, et al. Effects of haemodialysis and kidney transplantation on carotid and cardiopulmonary baroreflexes in uremic patients. J Hypertens 1987; 5 (Suppl 5):S367-S369.
25. Charlesworth JA, Kriketos AD, Jones JE, Erlich JH, Campbell LV, Peake PW. Insulin resistance and postprandial triglyceride levels in primary renal disease. Metabolism 2005; 54:821-828.
26. Berne C, Fagius J, Pollare T, Hjemdahl P. The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 1992; 35:873-879.
27. Mallamaci F, Tripepi G, Maas R, Malatino L, Böger R, Zoccali C. Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease. J Am Soc Nephrol 2004; 15:435-441.
28. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 1998; 31:68-72.
29. Grassi G. Counteracting the sympathetic nervous system in essential hypertension. Curr Opin Nephrol Hypertens 2004; 13:513-519.
30. Grassi G. Sympathetic and baroreflex function in hypertension: implications for current and new drugs. Curr Pharm Des 2004; 10:3579-3589.
31. Grassi G, Esler M. How to assess sympathetic activity in humans. J Hypertens 1999; 17:719-734.
32. Ferrier C, Esler MD, Eisenhofer G, Wallin BG, Horne M, Cox HS, et al. Increased norepinephrine spillover into the jugular veins in essential hypertension. Hypertension 1992; 19:62-69.
33. Middlekauff HR, Hamilton MA, Stevenson LW, Mark AL. Independent control of skin and muscle sympathetic nerve activity in patients with heart failure. Circulation 1994; 90:1794-1798.
34. Kaye DM, Lambert GW, Lefkovits J, Morris M, Jennings G, Esler MD. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol 1994; 23:570-578.
35. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 1997; 96:3423-3429.